Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sartorius to acquire three Danaher life science businesses for $750mm

Executive Summary

Sartorius AG and its independent subgroup Sartorius Stedim Biotech SA (SSB) agreed to acquire three of Danaher Corp.'s life science businesses: ForteBio Inc., Pall-Chromatography, and SoloHill Engineering Inc. The three segments together had combined revenues of approximately $70mm in 2018 as well as double-digit profit margins. The proposed transaction is expected to be completed in Q1 2020 and is contingent upon the success of Danaher’s pending $21.4bn acquisition of the biopharma business of GE Healthcare Life Sciences.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Synthesis Technologies, Production Processes
  • Medical Devices
    • Consumables, Central Supplies
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash
    • Acquisition of Private Biotech
    • Intra-Biotech Deal

Related Companies